BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 30753318)

  • 1. Type I interferon protects neurons from prions in in vivo models.
    Ishibashi D; Homma T; Nakagaki T; Fuse T; Sano K; Satoh K; Mori T; Atarashi R; Nishida N
    Brain; 2019 Apr; 142(4):1035-1050. PubMed ID: 30753318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Protective Role of the Host Innate Immune System in Prion Pathogenesis].
    Ishibashi D
    Yakugaku Zasshi; 2019; 139(7):993-998. PubMed ID: 31257258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. THαβ Immunological Pathway as Protective Immune Response against Prion Diseases: An Insight for Prion Infection Therapy.
    Tsou A; Chen PJ; Tsai KW; Hu WC; Lu KC
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35216001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective role of interferon regulatory factor 3-mediated signaling against prion infection.
    Ishibashi D; Atarashi R; Fuse T; Nakagaki T; Yamaguchi N; Satoh K; Honda K; Nishida N
    J Virol; 2012 May; 86(9):4947-55. PubMed ID: 22379081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prion Protein Devoid of the Octapeptide Repeat Region Delays Bovine Spongiform Encephalopathy Pathogenesis in Mice.
    Hara H; Miyata H; Das NR; Chida J; Yoshimochi T; Uchiyama K; Watanabe H; Kondoh G; Yokoyama T; Sakaguchi S
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective role of MyD88-independent innate immune responses against prion infection.
    Ishibashi D; Atarashi R; Nishida N
    Prion; 2012; 6(5):443-6. PubMed ID: 23093799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased cell surface prion protein in mouse models of prion disease.
    Griffin JK; Terry LA; Jackman R; Yousefi M; Cashman NR
    Neuroreport; 2007 Jan; 18(1):1-6. PubMed ID: 17259851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene knockout of tau expression does not contribute to the pathogenesis of prion disease.
    Lawson VA; Klemm HM; Welton JM; Masters CL; Crouch P; Cappai R; Ciccotosto GD
    J Neuropathol Exp Neurol; 2011 Nov; 70(11):1036-45. PubMed ID: 22002429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guinea Pig Prion Protein Supports Rapid Propagation of Bovine Spongiform Encephalopathy and Variant Creutzfeldt-Jakob Disease Prions.
    Watts JC; Giles K; Saltzberg DJ; Dugger BN; Patel S; Oehler A; Bhardwaj S; Sali A; Prusiner SB
    J Virol; 2016 Nov; 90(21):9558-9569. PubMed ID: 27440899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of prion protein in transmission of prions and in pathogenesis of spongiform encephalopathies].
    Raeber AJ; Klein MA; Frigg R; Brandner S; Blättler T; Aguzzi A
    Wien Med Wochenschr; 1998; 148(4):74-7. PubMed ID: 9611346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transmission and Replication of Prions.
    Marín-Moreno A; Fernández-Borges N; Espinosa JC; Andréoletti O; Torres JM
    Prog Mol Biol Transl Sci; 2017; 150():181-201. PubMed ID: 28838661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a new largely scalable in vitro prion propagation method for the production of infectious recombinant prions for high resolution structural studies.
    Eraña H; Charco JM; Di Bari MA; Díaz-Domínguez CM; López-Moreno R; Vidal E; González-Miranda E; Pérez-Castro MA; García-Martínez S; Bravo S; Fernández-Borges N; Geijo M; D'Agostino C; Garrido J; Bian J; König A; Uluca-Yazgi B; Sabate R; Khaychuk V; Vanni I; Telling GC; Heise H; Nonno R; Requena JR; Castilla J
    PLoS Pathog; 2019 Oct; 15(10):e1008117. PubMed ID: 31644574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propagation and Dissemination Strategies of Transmissible Spongiform Encephalopathy Agents in Mammalian Cells.
    Heumüller SE; Hornberger AC; Hebestreit AS; Hossinger A; Vorberg IM
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prion encephalopathies of animals and humans.
    Prusiner SB
    Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-prion drugs do not improve survival in novel knock-in models of inherited prion disease.
    Walsh DJ; Rees JR; Mehra S; Bourkas MEC; Kaczmarczyk L; Stuart E; Jackson WS; Watts JC; Supattapone S
    PLoS Pathog; 2024 Apr; 20(4):e1012087. PubMed ID: 38557815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The spread of prions through the body in naturally acquired transmissible spongiform encephalopathies.
    Beekes M; McBride PA
    FEBS J; 2007 Feb; 274(3):588-605. PubMed ID: 17288548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune system and peripheral nerves in propagation of prions to CNS.
    Aguzzi A; Heppner FL; Heikenwalder M; Prinz M; Mertz K; Seeger H; Glatzel M
    Br Med Bull; 2003; 66():141-59. PubMed ID: 14522856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral Prion Neuroinvasion Occurs Independently of PrP
    Marshall A; Bradford BM; Clarke AR; Manson JC; Mabbott NA
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CNS pathogenesis of prion diseases.
    Brandner S
    Br Med Bull; 2003; 66():131-9. PubMed ID: 14522855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular biology and pathogenesis of prion diseases.
    Prusiner SB
    Trends Biochem Sci; 1996 Dec; 21(12):482-7. PubMed ID: 9009832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.